Design, Synthesis, and Pharmacological Evaluation of Piperazine Hydrazide Derivatives as Potential CNS-Active Antidepressants: MAO-A Inhibition and In Silico Docking Studies on Protein 2BXR and N1 Neuraminidase (PDB 2HU4) for Alzheimer’s Disease . CDF [Internet]. 2025 Jan. 10 [cited 2025 Sep. 17];54(2):1594-611. Available from: https://cuestionesdefisioterapia.com/index.php/es/article/view/890